Protara Therapeutics, Inc. (TARA)

3.97 +0.03 (+0.76%) USD  |  NASDAQ  |  Sep 03, 16:00
3.965 0.00 (0.00%) Pre-Market: 20:00
More

Protara Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for TARA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2014. Start Trial.
Date Value
December 31, 2014 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
NovelStem International Corp. --
Brainstorm Cell Therapeutics, Inc. --
Summit Therapeutics, Inc. --
Kezar Life Sciences, Inc. --
Clene, Inc. Upgrade